跳至主要内容
临床试验/KCT0009260
KCT0009260招募中Unknown

Intravenous versus oral iron supplementation for iron deficiency anemia in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy: A prospective randomized clinical trial

Chonnam National University Hospital Hwasun Hospital0 个研究点目标入组 94 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
94

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20(Year) 至 o Limit(—)
性别
All

入选标准

  • Patients with primary rectal cancer without distant metastases
  • - Age 20 or older
  • - patients who agree to participate in this study and sign the clinical trial consent form
  • - Iron deficiency anemia
  • : Hemoglobin <12g/dL for women, hemoglobin <13g/dL for men
  • Serum ferritin <30 ng/mL
  • Serum transferrin saturation (TSAT) <20%
  • - Patients scheduled to receive neoadjuvant chemotherapy

排除标准

  • - requiring emergency surgery due to obstruction, perforation, etc.
  • - received a blood transfusion within 1 month of screening
  • - Serum ferritin >800 ng/mL
  • - pregnant woman
  • - contraindicated in the use of Perinect Injection or Ferovayl Released Tablet
  • - ASA score >3
  • - If erythropoietin stimulating agent was used within 3 months of screening
  • - Chronic renal disease (Glomerular filtration rate <30 ml/min/m)
  • - Increased serum AST (GOT) and ALT (GPT) (more than 3 times normal)
  • - Myelodysplastic sybdrome
  • - hereditary hemochromatosis
  • - thalassemia
  • - Hemolytic anemia
  • - History of abdominal surgery (The following do not meet the exclusion criteria: appendectomy, cholecystectomy, benign gynecological surgery – oophorectomy, cesarean section, simple hysterectomy for myoma)

研究者

发起方
Chonnam National University Hospital Hwasun Hospital

相似试验